Product Information
MAXALT MLT 10 MG TABLET is a brand product labeled by Organon LLC, priced at $44.2223 per EA under NDC 78206014301. Its NADAC has been published 123 times since Apr 17, 2024.
FDA first approved this application on Jun 29, 1998. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the rizatriptan benzoate market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10 mg/1
Manufacturer
Organon LLCNDC
78206014301
Classification
Brand
Dosage Form
TABLET, ORALLY DISINTEGRATING
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
RIZATRIPTAN BENZOATEApproval Type
New Drug (NDA)
FDA Application
NDA020865FDA Approved
6/29/1998
TE Code
AB
On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for MAXALT MLT 10 MG TABLET has been published 123 times since Apr 17, 2024, and over the history we have for it it has risen 9.8%. The table below summarizes its recorded NADAC range and movement.
| Current price | $44.2223 per EA |
|---|---|
| All-time high | $44.3130 (May 13, 2026) |
| All-time low | $40.2604 (Apr 17, 2024) |
| 52-week high | $44.3130 |
| 52-week low | $42.1854 |
| Median price | $42.2565 |
| Average price | $42.2055 |
| Largest weekly change | +5.0% (Jan 1, 2025) |
| Weeks tracked | 123 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 4 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of MAXALT MLT 10 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for MAXALT MLT 10 MG TABLET, manufactured by Organon LLC, is $44.2223 per EA (NDC 78206014301), effective Aug 19, 2026.
How has the price of MAXALT MLT 10 MG TABLET changed over time?
Over the history we have for it, the NADAC for MAXALT MLT 10 MG TABLET has risen 9.8%. It has been tracked across 123 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for MAXALT MLT 10 MG TABLET?
Since Apr 17, 2024, the NADAC for MAXALT MLT 10 MG TABLET has ranged from a low of $40.2604 (Apr 17, 2024) to a high of $44.3130 (May 13, 2026), with a median of $42.2565 per EA.
Are there cheaper alternatives to MAXALT MLT 10 MG TABLET?
Yes. 4 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, RIZATRIPTAN 10 MG ODT, is $0.5103 per EA — about 99% below MAXALT MLT 10 MG TABLET.
Who manufactures MAXALT MLT 10 MG TABLET?
MAXALT MLT 10 MG TABLET (NDC 78206014301) is labeled by Organon LLC, and CMS classifies it as a brand product.